Panelists discuss the dosing schedule and patient education related to tivozanib, along with indications for potential treatment switch based on toxicity management and patient well-being.
Exciting New Treatment Updates Are on the Horizon for Advanced RCC
Moshe Ornstein, MD, highlights recent treatment updates for renal cell carcinoma.
Oncology On-The-Go Podcast: Integrative and Palliative Kidney Cancer Care
Santosh Rao, MD, discusses the formation of new guidelines informing the use of integrative oncology for patients with kidney cancer from the Society for Integrative Oncology.
Toripalimab Combo Receives Chinese Approval for Advanced RCC
Toripalimab plus axitinib is now an approved regimen in China for patients with medium- to high-risk unresectable or metastatic renal cell carcinoma.
OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC
In an OncView™ program, David H. Aggen, MD, PhD, Robert S. Alter, MD, Arnab Basu, MD, MPH, FACP, Mehmet Asim Bilen, MD, and Chung-Han Lee, MD, MPH, offer their expert insights for the treatment of RCC.
Comparable Findings in White and Black Populations for ICI Use in Metastatic RCC
Practices should not differentiate treatment options based on race for patients with metastatic renal cell carcinoma, according to Jasmeet Kaur, MD.
Belzutifan Improves QoL and Disease Progression Time in Advanced Kidney Cancer
Treatment with belzutifan increased the time to disease progression, according to findings from the LITESPARK-005 trial.